Nest Genomics is software for health systems that automatically creates personalized care plans for patients who had genetic testing. For example, if someone is at risk for breast cancer, we provide a personalized plan that includes imaging, referrals to specialists and medication that can help prevent cancer.
I'm a co-founder and COO of Nest Genomics (W22). Until recently, I led SaaS teams at Invitae (NVTA), a global genetics company. I was the co-founder and COO of ClearGenetics (W17, acquired by Invitae), which developed innovative software for integrating genetics into routine care. Before that, I held senior product roles at Twitter, SnappyTV and Google/Motorola. I'm a Mammram Alum, hold a Bachelor’s in Computer Science and MBA from Duke and Tel-Aviv University.
Prior to starting Clear Genetics (acquired by NVTA), Moran held several roles focused on increasing access and education to genetic testing in Israel. She was also at Medtronic, where she did business development and led business strategy. Moran did software engineering in Israel's military (Mammram), studied Biomedical engineering, and has an MBA from Wharton with a major in healthcare management.